Related Experiment Video
Updated: Sep 28, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
RhoGDI2 is an invasion and metastasis suppressor gene in human cancer
John J Gildea1, M Jabed Seraj, Gary Oxford
1Department of Molecular Physiology and Biological Physics, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
Abstract:
To discover novel metastasis suppressor genes that are clinically relevant in common human cancers, we used isogenic human bladder cancer cell lines and used DNA microarray technology to identify genes whose expression diminishes as a function of invasive and metastatic competence. We then evaluated the expression profile of such genes in 105 pathologically characterized tumors from seven common organ sites, and we identified one gene, RhoGDI2, whose expression was diminished as a function of primary tumor stage and grade. When RhoGDI2 was transferred back into cells with metastatic ability that lacked its expression, it suppressed experimental lung metastasis but did not affect in vitro growth, colony formation, or in vivo tumorigenicity. In addition, RhoGDI2 reconstitution in these cells blocked invasion in an organotypic assay and led to a reduction of in vitro motility. These results indicate that RhoGDI2 is a metastasis suppressor gene, a marker of aggressive human cancer, and a promising target for therapy.
Insights
Researchers identified RhoGDI2 as a novel metastasis suppressor gene. Its diminished expression correlates with aggressive cancers, and restoring it inhibits cancer spread and invasion.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastasis is a complex process driven by genetic alterations.
- Identifying metastasis suppressor genes is crucial for cancer therapy.
- Understanding gene expression changes in invasive cancers is key.
Purpose of the Study:
- To discover novel, clinically relevant metastasis suppressor genes in human cancers.
- To identify genes downregulated during cancer invasion and metastasis.
- To evaluate the therapeutic potential of identified genes.
Main Methods:
- Utilized isogenic human bladder cancer cell lines and DNA microarray technology.
- Analyzed gene expression profiles in 105 human tumors across seven organ sites.
- Performed gene transfer experiments to assess functional impact on metastasis.
Main Results:
- Identified RhoGDI2 (Rho Guanine Dissociation Inhibitor 2) as a gene downregulated with increasing tumor stage and grade.
- Restoring RhoGDI2 expression suppressed experimental lung metastasis in cancer cells.
- RhoGDI2 reconstitution inhibited cancer cell invasion and reduced motility without affecting growth or tumorigenicity.
Conclusions:
- RhoGDI2 functions as a metastasis suppressor gene.
- RhoGDI2 is a potential biomarker for aggressive human cancers.
- RhoGDI2 represents a promising therapeutic target for inhibiting cancer metastasis.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

